Healthcare
11 October 2012
Globalisation of innovation: Heptares
This special feature, in partnership with UK Trade & Investment, the UK government’s department focused on supporting exporters and inward investors, looks at how the corporate venturing unit of Japan-based pharmaceutical company Takeda came to back fast-growing UK company Heptares, which owns a breakthrough medical technology described by a Takeda executive as the “holy grail for pharma”. It is the first in our Globalisation of innovation series, looking at a showcase deal demonstrating how corporates from specific countries have invested in start-ups overseas.
In April last year UK-based biotechnology company Heptares Therapeutics simultaneously sealed a two-year drug discovery collaboration with Japan-based pharmaceutical company Takeda and an equity investment from its corporate venturing unit Takeda Ventures.The move aligned Takeda with a British company that has developed a highly sought after…Read More.
Supporting articles: Healthcare welcomes latest fund
14 June 2012
Healthcare 2012: Well-being defines a growing sector
The past 12 months has seen the healthcare sector cross an important milestone as more than 100 companies now have corporate venturing units.The traditional leaders in corporate venturing, such as…
14 June 2012
Some healthy opportunities
Healthcare might be undergoing some macro-challenges as governments worry about how they will pay for people's health in their old age, but it is also throwing up opportunities for non-traditional…
- 14 June 2012 – Profile: Johnson & Johnson Development Corporation
- 5 June 2011 – Feature: Healthcare sector 2011
- 3 June 2011 – Profile: Cleveland Clinic Innovations
- 3 June 2011 – Case study: Avid Radiopharmaceuticals
- 3 June 2011 – Venture philanthropy in healthcare
- 4 October 2010 – Third Rock incubates new venture capital model
- 1 June 2010 – Top 75 Most Influential Healthcare Corporate Venturing Divisions
- 1 June 2010 – Rivalry is no reason to miss a good business move
- 1 June 2010 – First investment illustrates value in working together
- 1 June 2010 – Biotech companies call in the colonel
- 1 June 2010 – Move to create in-house venture team vindicated
- 1 June 2010 – VCs work with their corporate peers
- 1 June 2010 – Four work in tandem in novel approach to start-ups
